CHPA elections
This article was originally published in The Tan Sheet
Executive Summary
Leiner, Insight Pharmaceuticals, Taro Pharmaceuticals among six new active members elected during CHPA's board of directors meeting in New York Nov. 19; three new associate members also join the group. CHPA board elected two directors to fill open slots: Steven LaMonte, Schering-Plough senior VP-marketing, will take seat vacated by Mark Kirn, who recently was promoted to president-international business development at Schering. Lynne Millheiser, Novartis senior VP-OTC business unit, will complete term previously held by Michel Orsinger, whose duties at Novartis keep him too busy for board responsibilities, CHPA says...